Technology Readiness Level (TRL) Connections to Early Drug Discovery and Development (TRLs 1-3: Pre-Concept)

Previously we wrote about Biomedical and Line (non-medical) Department of Defense (DoD) Technology Readiness Levels (TRLs) and medical countermeasure (MCM) TRLs and discussed how a technology may develop through each TRL stage. Here, we will provide additional details on how biomedical TRLs apply specifically to early discovery and development (i.e., TRLs 1-3) drug, biologic or vaccine decision points for new chemical entities (NCE).

DoD biomedical-related technologies require TRL definitions ...

Continue Reading →